While proliferation of OV90/OV90cp was reduced to 72%/76% after 48 h CP monotherapy (Fig. 5B), the combination of CP with 1 μM MPA demonstrated a more substantial decrease in proliferation of cancer cells to 56%/65%. This evidence concerns the gene CP and cancer.